Omburtamab for treating relapsed neuroblastoma [ID1664]

  • In development
  • GID-TA10608
  • Expected publication date: TBC

Documents

Documents created during the development process.

Topic selection

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators